This is a preview of subscription content, log in via an institution to check access.
Reference
Iso H, et al. Remarkable Clinical Response of ALK-Rearranged/ TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and Therapy 16: 465-470, Jan 2023. Available from: URL: 10.2147/OTT.S404035
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 2007, 263 (2024). https://doi.org/10.1007/s40278-024-58823-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-58823-x